ascididemin has been researched along with isoniazid in 2 studies
| Studies (ascididemin) | Trials (ascididemin) | Recent Studies (post-2010) (ascididemin) | Studies (isoniazid) | Trials (isoniazid) | Recent Studies (post-2010) (isoniazid) |
|---|---|---|---|---|---|
| 23 | 0 | 10 | 21,815 | 960 | 4,493 |
| Protein | Taxonomy | ascididemin (IC50) | isoniazid (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 4.85 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 8.29 | |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | 4.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, HC; Copp, BR; G Franzblau, S; Lindsay, BS | 1 |
| Cappoen, D; Claes, P; De Kimpe, N; Huygen, K; Jacobs, J; Mathys, V; Mbala, BM; Mertens, B; Verschaeve, L | 1 |
2 other study(ies) available for ascididemin and isoniazid
| Article | Year |
|---|---|
Identification of heteroarylenamines as a new class of antituberculosis lead molecules.
Topics: Amines; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance; Inhibitory Concentration 50; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2005 |
Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine.
Topics: Alkaloids; Anthraquinones; Anti-Bacterial Agents; Aza Compounds; Biological Products; Dose-Response Relationship, Drug; Heterocyclic Compounds, 4 or More Rings; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Naphthyridines; Structure-Activity Relationship | 2013 |